Get the Stockscreener App
377.13
2.44%
9.00
After Hours:
377.13
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Waters Corp stock is traded at $377.13, with a volume of 531.25K.
It is up +2.44% in the last 24 hours and up +1.61% over the past month.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.
See More
Previous Close:
$368.13
Open:
$371.74
24h Volume:
531.25K
Relative Volume:
0.53
Market Cap:
$37.03B
Revenue:
$3.77B
Net Income/Loss:
$449.25M
P/E Ratio:
48.01
EPS:
7.8556
Net Cash Flow:
$240.68M
1W Performance:
-0.57%
1M Performance:
+1.61%
6M Performance:
-4.95%
1Y Performance:
+8.00%
1-Day Range:
$371.23
$381.32
1-Week Range:
$367.06
$383.52
52-Week Range:
$275.05
$414.15
Waters Corp Stock (WAT) Company Profile
Name
Waters Corp
Sector
Industry
Phone
(508) 478-2000
Address
34 MAPLE ST, MILFORD, MA
Compare WAT vs TMO, DHR, IDXX, NTRA, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
377.13 | 36.15B | 3.77B | 449.25M | 240.68M | 7.8556 |
TMO
Thermo Fisher Scientific Inc
|
524.71 | 189.58B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
195.98 | 135.02B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
558.60 | 43.83B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
281.85 | 39.30B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
133.59 | 36.45B | 7.23B | 1.41B | 1.09B | 4.979 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-06-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-10-26 | Resumed | Barclays | Overweight |
| Feb-10-26 | Resumed | Citigroup | Buy |
| Feb-10-26 | Resumed | Evercore ISI | In-line |
| Jan-06-26 | Initiated | Guggenheim | Buy |
| Jan-05-26 | Initiated | William Blair | Outperform |
| Dec-10-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-02-25 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-08-25 | Initiated | Rothschild & Co Redburn | Buy |
| Mar-31-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-26-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Feb-10-25 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-08-24 | Upgrade | Jefferies | Hold → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Aug-01-24 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Nov-13-23 | Downgrade | Barclays | Equal Weight → Underweight |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| May-18-22 | Initiated | Barclays | Overweight |
| May-17-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Apr-25-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-07-21 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Dec-17-20 | Upgrade | Cleveland Research | Underperform → Buy |
| Dec-16-20 | Upgrade | Citigroup | Sell → Neutral |
| Dec-02-20 | Initiated | Goldman | Neutral |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jul-28-20 | Upgrade | JP Morgan | Underweight → Neutral |
| Jul-16-20 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jan-08-20 | Downgrade | Needham | Hold → Underperform |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Initiated | Citigroup | Sell |
| Nov-15-19 | Initiated | Stifel | Hold |
| Oct-09-19 | Downgrade | Barclays | Equal Weight → Underweight |
| Jul-16-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jun-12-19 | Downgrade | Cleveland Research | Neutral → Underperform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| Jan-24-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-03-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jan-03-19 | Initiated | Needham | Hold |
| Dec-12-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Nov-30-18 | Downgrade | Goldman | Neutral → Sell |
| Oct-11-18 | Upgrade | Cleveland Research | Sell → Neutral |
View All
Waters Corp Stock (WAT) Latest News
Waters Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Waters Corporation (WAT) Gains as RBC Initiates Coverage with Ou - GuruFocus
Waters Corp. Coin Cell DSC: Direct Thermal and Gas Analysis for Battery SafetyNews and Statistics - IndexBox
RBC Capital initiates Waters stock coverage with outperform rating - Investing.com
Waters Corp : RBC Initiates Coverage With Out - Moomoo
Waters Corporation outlines its role in analytical science as investors watch long-term growth drive - AD HOC NEWS
Caribbean Airlines drops Blue Waters from in-flight service - Trinidad Guardian
Waters Corporation business model and stock context for long-term investors - AD HOC NEWS
The Waters ACQUITY UPLC H-Class PLUS Bio. A quieter upgrade for biopharma labs - Ad-hoc-news.de
Overcoming Analytical Bottlenecks in Advanced Therapies Development - Technology Networks
Waters Corporation highlights analytical instrumentation strength as a global life sciences supplier - AD HOC NEWS
Fidelity Mid Cap Value Index Fund's Waters Corp(WAT) Holding History - GuruFocus
WATWaters Corp Options - Finviz
Waters Corporation focuses on analytical instruments as investors watch long-term growth - AD HOC NEWS
Waters Corporation focuses on analytical science amid steady demand - Ad-hoc-news.de
Waters stock tracks its core lab testing business. - Ad-hoc-news.de
[Form 4] WATERS CORP /DE/ Insider Trading Activity - Stock Titan
Waters Corp (WAT) director Wei Jiang granted 67.42 deferred stock units - Stock Titan
Waters Corp explores growth opportunities as demand for analytical instruments stays resilient - Ad-hoc-news.de
Waters to hold Q2 2026 results call Aug. 4, webcast set - Stock Titan
Waters Corporation highlights analytical science role amid steady industry demand - Ad-hoc-news.de
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch
Waters Corp. stock underperforms Monday when compared to competitors - MarketWatch
Waters Corporation with a clear analyst view, shares trade steadily on the NYSE - AD HOC NEWS
ACQUITY Premier System from Waters Corpmetal free flow path for tougher separations - Ad-hoc-news.de
Waters Corp (WAT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Bernstein SocGen resumes Waters stock coverage with outperform rating - Investing.com UK
Waters (WAT) Receives Outperform Rating with $435 Target from Be - GuruFocus
Bernstein SocGen resumes Waters stock coverage with outperform rating By Investing.com - Investing.com Australia
WAT Reinstated by Bernstein -- Rating Upgraded to Outperform - GuruFocus
Waters Corporation clears a fresh analyst mark, shares trade higher on Xetra and NYSE - AD HOC NEWS
Form 4 Waters Corporation For: 25 June By Investing.com - Investing.com Australia
Waters (NYSE: WAT) SVP has 189 shares withheld to cover RSU tax - Stock Titan
SNT Biotech Announces a Partnership with Waters Corporation to Bring the Most Comprehensive FDA-Cleared At-Home HPV Cervical Cancer Screening Tool Available in the U.S. Today to Patients - The AI Journal
Waters, IMU Biosciences partner to accelerate AI immune mapping for precision medicineVietnam Investment Review - Vietnam Investment Review - VIR
Waters Corp (WAT) Stock Up 3.4% and Still Undervalued -- GF Scor - GuruFocus
Waters Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Global Laboratory Equipment Services Market Size/Share Worth USD 62.83 Billion by 2035 at a 8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
IMU Biosciences, Waters form AI immunology partnership - Investing.com
Waters backs IMU’s AI blood test platform for cancer and other diseases - Stock Titan
Waters Corporation (WAT): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance
Waters Corp (WAT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Waters Corp (WAT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Waters opens the week with earnings focus, shares on NYSE - AD HOC NEWS
Waters Corporation stock: Is WAT underperforming the health care sector? - MSN
Xevo TQ-XS Mass Spectrometer from Waters Corphighly sensitive LC-MS/MS for demanding labs - AD HOC NEWS
Waters StockSunday background on lab-analytics specialist - Ad-hoc-news.de
Precision workflows in the lab, Waters Xevo TQ Absolute quietly pushes LC-MS sensitivity - AD HOC NEWS
Smart workflows at the bench, Waters ACQUITY Arc Bio helps labs keep up - AD HOC NEWS
Subtle but forensic, Waters ACQUITY Premier UHPLC targets stubborn metals - AD HOC NEWS
Waters Corp (WAT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Waters Corp Stock (WAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):